• No results found

University of Groningen Relapse prevention strategies for recurrent depression Klein, Nicola Stephanie

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Relapse prevention strategies for recurrent depression Klein, Nicola Stephanie"

Copied!
19
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Relapse prevention strategies for recurrent depression

Klein, Nicola Stephanie

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2019

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Klein, N. S. (2019). Relapse prevention strategies for recurrent depression. Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)
(3)

Acosta, F., Rodríguez, L., & Cabrera, B. (2013). Beliefs about depression and its treatments: associated variables and the influence of beliefs on adherence to treatment. Revista de Psiquiatría y Salud Mental (English Edition),

6(2), 86–92. doi:10.1016/j.rpsm.2012.08.001

Ahern, E., Kinsella, S., & Semkovska, M. (2018). Clinical efficacy and economic evaluation of online cognitive behavioral therapy for major depressive disorder: a systematic review and meta-analysis. Expert Review of

Pharmacoeconomics & Outcomes Research, 18(1), 25–41. doi:10.1080/14737167.2018.1407245

Aikens, J. E., & Klinkman, M. S. (2012). Changes in patients’ beliefs about their antidepressant during the acute phase of depression treatment. General Hospital Psychiatry, 34(3), 221–226. doi:10.1016/j.gen-hosppsych.2012.01.004

Aikens, J. E., Kroenke, K., Swindle, R. W., & Eckert, G. J. (2005). Nine-month predictors and outcomes of SSRI antidepressant continuation in primary care. General Hospital Psychiatry, 27(4), 229–236. doi:10.1016/j.gen-hosppsych.2005.04.001

Aikens, J. E., Nease, D. E. Jr., & Klinkman, M. S. (2008). Explaining patients’ beliefs about the necessity and harm-fulness of antidepressants. Annals of Family Medicine, 6(1), 23–29. doi:10.1370/afm.759

Ajzen, I. (1988). Attitudes, personality, and behavior. Homewood, IL: Dorsey Press.

American Psychiatric Association. (2010). Practice guideline for the treatment of patients with major depressive

Disorder, third edition. Retrieved from: http://psychiatryonline.org/guidelines.

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arling-ton, VA: American Psychiatric Publishing.

Andersson, G., & Cuijpers, P. (2009). Internet-based and other computerized psychological treatments for adult depression: a meta-analysis. Cognitive Behaviour Therapy, 38(4), 196–205. doi:10.1080/16506070903318960 Andersson, G., Rozental, A., Shafran, R., & Carlbring, P. (2018). Long-term effects of internet-supported cognitive

behaviour therapy. Expert Review of Neurotherapeutics, 18(1), 21–28. doi:10.1080/14737175.2018.1400381 Andrews, P. W., Kornstein, S. G., Halberstadt, L. J., Gardner, C. O., & Neale, M. C. (2011). Blue again:

perturba-tional effects of antidepressants suggest monoaminergic homeostasis in major depression. Frontiers in

Psy-chology, 2, 1–24. doi:10.3389/fpsyg.2011.00159

Andrews, P. W., Thomson, J. A., Amstadter, A., & Neale, M. C. (2012). Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good. Frontiers in Psychology, 3, 1–19. doi:10.3389/ fpsyg.2012.00117

Angermeyer, M. C., & Dietrich, S. (2006). Public beliefs about and attitudes towards people with mental ill-ness: a review of population studies. Acta Psychiatrica Scandinavica, 113(3), 163–179. doi:10.1111/j.1600-0447.2005.00699.x

Arnberg, F. K., Linton, S. J., Hultcrantz, M., Heintz, E., & Jonsson, U. (2014). Internet-delivered psychological treatments for mood and anxiety disorders: a systematic review of their efficacy, safety, and cost-effectiveness.

PLoS ONE, 9(5), 1–13. doi:10.1371/journal.pone.0098118

Badger, F., & Nolan, P. (2007). Attributing recovery from depression. Perceptions of people cared for in primary care. Journal of Clinical Nursing, 16(3A), 25–34. doi:10.1111/j.1365-2702.2006.01581.x

Balon, R. (2006). Mood, anxiety, and physical illness: body and mind, or mind and body? Depression and Axiety,

23(6), 377–387. doi:10.1002/da.20217

Bauer, A. M., Parker, M. M., Schillinger, D., Katon, W., Adler, N., Adams, A. S., … Karter, A. J. (2014). Associ-ations between antidepressant adherence and shared decision-making, patient-provider trust, and communi-cation among adults with diabetes: Diabetes Study of Northern California (DISTANCE). Journal of General

Internal Medicine, 29(8), 1139–1147. doi:10.1007/s11606-014-2845-6

Baumeister, H., Reichler, L., Munzinger, M., & Lin, J. (2014). The impact of guidance on Internet-based mental health interventions - a systematic review. Internet Interventions, 1(4), 205–215. doi:10.1016/j.invent.2014.08.003 Beck, A. T., Rush, A. J., Shaw, B. F., & Emery, G. (1979). Cognitive therapy of depression. New York, NY: Guilford

Press.

Benton, T., Staab, J., & Evans, D. L. (2007). Medical co-morbidity in depressive disorders. Annals of Clinical

Psychiatry, 19(4), 289–303. doi:10.1080/10401230701653542

Bernardini, F., Attademo, L., Cleary, S. D., Luther, C., Shim, R. S., Quartesan, R., & Compton, M. T. (2017). Risk prediction models in psychiatry. The Journal of Clinical Psychiatry, 78(5), 572–583. doi:10.4088/ JCP.15r10003

(4)

interna-tional literature, a review. The Journal of Mental Health Policy and Economics, 3(1), 3–10. doi:10.1002/1099-176X(200003)3:13.0.CO;2-H

Beshai, S., Dobson, K. S., Bockting, C. L. H., & Quigley, L. (2011). Relapse and recurrence prevention in depres-sion: current research and future prospects. Clinical Psychology Review, 31(8), 1349–1360. doi:10.1016/j. cpr.2011.09.003

Biesheuvel-Leliefeld, K. E. M., Bosmans, J. E., Smit, F., Bockting, C. L. H., van Schaik, D. J. F., van Marwijk, H. W. J., van der Horst, H. E. (2018). Cost-effectiveness of supported self-help for recurrent depression in primary care. Under Review.

Biesheuvel-Leliefeld, K. E. M., Dijkstra-Kersten, S. M. A., van Schaik, D. J. F., van Marwijk, H. W. J., Smit, F., van der Horst, H. E., & Bockting, C. L. H. (2017). Effectiveness of supported self-help in recurrent de-pression: a randomized controlled trial in primary care. Psychotherapy and Psychosomatics, 86(4), 220–230. doi:10.1159/000472260

Biesheuvel-Leliefeld, K. E. M., Kok, G. D., Bockting, C. L. H., Cuijpers, P., Hollon, S. D., van Marwijk, H. W. J., & Smit, F. (2015). Effectiveness of psychological interventions in preventing recurrence of depressive disorder: meta-analysis and meta-regression. Journal of Affective Disorders, 174, 400–410. doi:10.1016/j. jad.2014.12.016

Black, W. C. (1990). The CE plane: a graphic representation of cost-effectiveness. Medical Decision Making, 10(3), 212–214. doi:10.1177/0272989X9001000308

Bockting, C. L. H., Elgersma, H. J., van Rijsbergen, G. D., de Jonge, P., Ormel, J., Buskens, E., … Hollon, S. D. (2011). Disrupting the rhythm of depression: design and protocol of a randomized controlled trial on pre-venting relapse using brief cognitive therapy with or without antidepressants. BMC Psychiatry, 11(8), 1–22. doi:10.1186/1471-244X-11-8

Bockting, C. L. H., Hollon, S. D., Jarrett, R. B., Kuyken, W., & Dobson, K. (2015). A lifetime approach to major depressive disorder: the contributions of psychological interventions in preventing relapse and recurrence.

Clinical Psychology Review, 41, 16–26. doi:10.1016/j.cpr.2015.02.003

Bockting, C. L. H. (2009). Preventive cognitive therapy for recurrent depression. Houten: Bohn Stafleu van Lo-ghum.

Bockting, C. L. H., Klein, N. S., Elgersma, H. J., van Rijsbergen, G. D., Slofstra, C., Ormel, J., … Burger, H. (2018). Effectiveness of preventive cognitive therapy while tapering antidepressants compared with main-tenance antidepressant treatment and their combination in the prevention of depressive relapse or recurrence (DRD study): a three-arm randomised controlled. The Lancet Psychiatry, 5(5), 401-410. doi:10.1016/S2215-0366(18)30100-7

Bockting, C. L. H., Kok, G. D., van der Kamp, L., Smit, F., van Valen, E., Schoevers, R., … Beck, A. T. (2011). Disrupting the rhythm of depression using Mobile Cognitive Therapy for recurrent depression: randomized controlled trial design and protocol. BMC Psychiatry, 11(12), 1–9. doi:10.1186/1471-244X-11-12

Bockting, C. L. H., Schene, A. H., Spinhoven, P., Koeter, M. W. J., Wouters, L. F., Huyser, J., & Kamphuis, J. H. (2005). Preventing relapse/recurrence in recurrent depression with cognitive therapy: a randomized controlled trial. Journal of Consulting and Clinical Psychology, 73(4), 647–657. doi:10.1037/0022-006X.73.4.647 Bockting, C. L. H., Spinhoven, P., Koeter, M. W. J., Wouters, L. F., & Schene, A. H. (2006). Prediction of recurrence

in recurrent depression and the influence of consecutive episodes on vulnerability for depression: a 2-year pro-spective study. Journal of Clinical Psychiatry, 67(5), 747–755. doi:10.4088/JCP.v67n0508

Bockting, C. L. H., Spinhoven, P., Wouters, L. F., Koeter, M. W. J., & Schene, A. H. (2009). Long-term effects of preventive cognitive therapy in recurrent depression: a 5.5-year follow-up study. Journal of Clinical

Psychia-try, 70(12), 1621–1628. doi:10.4088/JCP.08m04784blu

Bockting, C. L. H., ten Doesschate, M. C., Spijker, J., Spinhoven, P., Koeter, M. W. J., & Schene, A. H. (2008). Con-tinuation and maintenance use of antidepressants in recurrent depression. Psychotherapy and Psychosomatics,

77(1), 17–26. doi:10.1159/000110056

Bockting, C. L. H., Smid, N. H., Koeter, M. W., Spinhoven, P., Beck, A. T., & Schene, A. H. (2015). Enduring effects of Preventive Cognitive Therapy in adults remitted from recurrent depression: a 10 year follow-up of a randomized controlled trial. Journal of Affective Disorders, 185, 188–194. doi:10.1016/j.jad.2015.06.048 Bockting, C. L. H., & van Valen, E. (2009). Ingredients of Mobile Preventive Cognitive therapy for recurrent

de-pression. The Netherlands.

(5)

15(4), 651–675. doi:10.1080/10705510802339072

Boerema, A. M., Kleiboer, A., Beekman, A. T. F., van Zoonen, K., Dijkshoorn, H., & Cuijpers, P. (2016). Determi-nants of help-seeking behavior in depression: a cross-sectional study. BMC Psychiatry, 16, 1–9. doi:10.1186/ s12888-016-0790-0

Bondolfi, G., Jermann, F., van der Linden, M., Gex-Fabry, M., Bizzini, L., Rouget, B. W., … Bertschy, G. (2010). Depression relapse prophylaxis with Mindfulness-Based Cognitive Therapy: replication and extension in the Swiss health care system. Journal of Affective Disorders, 122(3), 224–123. doi:10.1016/j.jad.2009.07.007 Borges, S., Chen, Y. F., Laughren, T. P., Temple, R., Patel, H. D., David, P. A., … Khin, N. A. (2014). Review of

maintenance trials for major depressive disorder: a 25-Year perspective from the US Food and Drug Adminis-tration. Journal of Clinical Psychiatry, 75(3), 205–214. doi:10.4088/JCP.13r08722

Bosman, R. C., Huijbrechts, K. M., Verhaak, P. F., Ruhé, H. G., van Marwijk, H. W., van Balkom, A. J., & Batelaan, N. M. (2016). Long-term antidepressant use: a qualitative study on perspectives of patients and GPs. British

Journal of General Practice, 66(651), 1–12. doi:10.3399/bjgp16X686641

Bouwmans, C., de Jong, K., Timman, R., Zijlstra-Vlasveld, M., van der Feltz-Cornelis, C., Tan Swan, S., & Hak-kaart-van Roijen, L. (2013). Feasibility, reliability and validity of a questionnaire on healthcare consumption and productivity loss in patients with a psychiatric disorder (TiC-P). BMC Health Services Research, 13(1),1– 9. doi:10.1186/1472-6963-13-217

Brazier, J., Connell, J., Papaioannou, D., Mukuria, C., Mulhern, B., Peasgood, T., … Parry, G. (2014). A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Health

Technology Assessment, 18(34), 1–188. doi:10.3310/hta18340

Bromet, E., Andrade, L. H., Hwang, I., Sampson, N. A., Alonso, J., de Girolamo, G., … Kessler, R. C. (2011). Cross-national epidemiology of DSM-IV major depressive episode. BMC Medicine, 9(1), 1–16. doi:10.1186/1741-7015-9-90

Brown, C., Battista, D. R., Sereika, S. M., Bruehlman, R. D., Dunbar-Jacob, J., & Thase, M. E. (2007). Primary care patients’ personal illness models for depression: relationship to coping behavior and functional disability.

General Hospital Psychiatry, 29(6), 492–500. doi:10.1016/j.genhosppsych.2007.07.007

Buckman, J. E. J., Underwood, A., Clarke, K., Saunders, R., Hollon, S. D., Fearon, P., & Pilling, S. (2018). Risk factors for relapse and recurrence of depression in adults and how they operate: a four-phase systematic review and meta-synthesis. Clinical Psychology Review, 64, 13–38. doi:10.1016/j.cpr.2018.07.005

Budd, R., James, D., & Hughes, I. (2008). Patients’ explanations for depression: a factor analytic study. Clinical

Psychology & Psychotherapy, 15(1), 28–37. doi:10.1002/cpp.558

Buntrock, C., Berking, M., Smit, F., Lehr, D., Nobis, S., Riper, H., … Ebert, D. (2017). Preventing depression in adults with subthreshold depression: health-economic evaluation alongside a pragmatic randomized controlled trial of a web-based intervention. Journal of Medical Internet Research, 19(1), e5. doi:10.2196/jmir.6587 Burcusa, S. L., & Iacono, W. G. (2007). Risk for recurrence in depression. Clinical Psychology Review, 27(8),

959–985. doi:10.1016/j.cpr.2007.02.005

Burton, A., Billingham, L. J., & Bryan, S. (2007). Cost-effectiveness in clinical trials: using multiple imputation to deal with incomplete cost data. Clinical Trials, 4(2), 154–161. doi:10.1177/1740774507076914

Buus, N., Johannessen, H., & Stage, K. B. (2012). Explanatory models of depression and treatment adherence to antidepressant medication: a qualitative interview study. International Journal of Nursing Studies, 49(10), 1220–1229. doi:10.1016/j.ijnurstu.2012.04.012

Carr, C. P., Martins, C. M., Stingel, A. M., Lemgruber, V. B., & Juruena, M. F. (2013). The role of early life stress in adult psychiatric disorders: a systematic review according to childhood trauma subtypes. Journal of Nervous

and Mental Disease, 201(12), 1007–1020. doi:10.1097/NMD.0000000000000049

Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016). The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature.

Psychother-apy and Psychosomatics, 85(5), 270–288. doi:10.1159/000447034

Chapman, D. P., Perry, G. S., & Strine, T. W. (2005). The vital link between chronic disease and depressive disor-ders. Preventing Chronic Disease, 2(1), 1–10.

Chekroud, A. M., Zotti, R. J., Shehzad, Z., Gueorguieva, R., Johnson, M. K., Trivedi, M. H., … Corlett, P. R. (2016). Cross-trial prediction of treatment outcome in depression: a machine learning approach. The Lancet

(6)

Chouinard, G., & Chouinard, V. A. (2015). New classification of selective serotonin reuptake inhibitor withdrawal.

Psychotherapy and Psychosomatics, 84(2), 63–71. doi:10.1159/000371865

Clarke, K., Mayo-Wilson, E., Kenny, J., & Pilling, S. (2015). Can non-pharmacological interventions prevent re-lapse in adults who have recovered from depression? A systematic review and meta-analysis of randomised controlled trials. Clinical Psychology Review, 39, 58–70. doi:10.1016/j.cpr.2015.04.002

Cleare, A., Pariante, C. M., Young, A. H., Anderson, I. M., Christmas, D., Cowen, P. J., … Members of the Con-sensus Meeting. (2015). Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines. Journal of Psychopharmacology,

29(5), 459–525. doi:10.1177/0269881115581093

Costantino, J. P., Gail, M. H., Pee, D., Anderson, S., Redmond, C. K., Benichou, J., & Wieand, H. S. (1999). Valida-tion studies for models projecting the risk of invasive and total breast cancer incidence. Journal of the NaValida-tional

Cancer Institute, 91(18), 1541–1548. doi:10.1093/jnci/91.18.1541

Croskerry, P., Singhal, G., & Mamede, S. (2013). Cognitive debiasing 1: origins of bias and theory of debiasing.

BMJ Quality and Safety, 22(SUPPL.2), 58–65. doi.10.1136/bmjqs2012-001712

Cuijpers, P., Beekman, A. T. F., & Reynolds, C. F. (2012). Preventing depression: a global priority. JAMA : The

Journal of the American Medical Association, 307(10), 1033–1034. doi:10.1001/jama.2012.271

D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008). General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation, 117(6), 743–753. doi:10.1161/CIRCULATIONAHA.107.699579

de Graaf, R., Bijl, R. V, Ravelli, A., Smit, F., & Vollebergh, W. A. (2002). Predictors of first incidence of DSM-III-R psychiatric disorders in the general population: findings from the Netherlands Mental Health Survey and Incidence Study. Acta Psychiatrica Scandinavica, 106(4), 303–313. doi:10.1034/j.1600-0447.2002.01397.x de Graaf, R., ten Have, M., van Gool, C., & van Dorsselaer, S. (2012). Prevalence of mental disorders and trends

from 1996 to 2009. Results from the Netherlands Mental Health Survey and Incidence Study-2. Social

Psychi-atry and Psychiatric Epidemiology, 47(2), 203–213. doi:10.1007/s00127-010-0334-8

de jonge, M., Bockting, C. L. H., van Dijk, M., van Schaik, D. J., Peen, J., Kikkert, M., & Dekker, J. J. (2018). Preventing depressive relapse and recurrence in cognitive therapy responders: a multicenter randomized con-trolled trial: Preventive Cognitive Therapy vs treatment as usual. Under Review.

Demyttenaere, K., Bruffaerts, R., Posada-Villa, J., Gasquet, I., Kovess, V., Lepine, J. P., … WHO World Mental Health Survey Consortium. (2004). Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA, 291(21), 2581–2590. doi:10.1001/ jama.291.21.2581

DeRubeis, R. J., Hollon, S. D., Amsterdam, J. D., Shelton, R. C., Young, P. R., Salomon, R. M., … Gallop, R. (2005). Cognitive Therapy vs Medications in the Treatment of Moderate to Severe Depression. Archives of

General Psychiatry, 62(4), 409–416. doi:10.1001/archpsyc.62.4.409

Donker, T., Blankers, M., Hedman, E., Ljótsson, B., Petrie, K., & Christensen, H. (2015). Economic evaluations of Internet interventions for mental health: a systematic review. Psychological Medicine, 45(16), 3357–3376. doi:10.1017/S0033291715001427

Donohue, J. M., & Pincus, H. A. (2007). Reducing the societal burden of depression: a review of economic costs, quality of care and effects of treatment. PharmacoEconomics, 25(1), 7–24. doi:10.2165/00019053-200725010-00003

Drozd, F., Vaskinn, L., Bergsund, H. B., Haga, S. M., Slinning, K., & Bjørkli, C. A. (2016). The implementa-tion of Internet intervenimplementa-tions for depression: a scoping review. Journal of Medical Internet Research, 18(9). doi:10.2196/jmir.5670

Drummond, M. F., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005). Methods for the

eco-nomic evaluation of health care programmes; third edition. Oxford: Oxford University Press.

Dziura, J. D., Post, L. A., Zhao, Q., Fu, Z., & Peduzzi, P. (2013). Strategies for dealing with missing data in clinical trials: from design to analysis. The Yale Journal of Biology and Medicine, 86(3), 343–358.

Eaton, W. W., Shao, H., Nestadt, G., Lee, B., Bienvenu, O. J., & Zandi, P. (2008). Populatibased study of first on-set and chronicity in major depressive disorder. Archives of General Psychiatry, 65(5), 513–520. doi:10.1001/ archpsyc.65.5.513.s

Efron, B., & Tibshirani, R. J. (1994). An introduction to the bootstrap. New York: Chapman & Hall/CRC. Enders, C. (2010). Applied Missing Data Analysis. In T. Little (Ed.), Methodology in the Social Sciences. New

(7)

York: The Guilford Press.

Erbe, D., Eichert, H. C., Riper, H., & Ebert, D. D. (2017). Blending face-to-face and Internet-based interventions for the treatment of mental disorders in adults: systematic review. Journal of Medical Internet Research, 19(9), e306. doi:10.2196/jmir.6588

Eveleigh, R., Grutters, J., Muskens, E., Oude Voshaar, R., van Weel, C., Speckens, A., & Lucassen, P. (2014). Cost-utility analysis of a treatment advice to discontinue inappropriate long-term antidepressant use in primary care. Family Practice, 31(5), 578–584. doi:10.1093/fampra/cmu043

Eysenbach, G., & CONSORT-EHEALTH Group. (2011). CONSORT-EHEALTH: improving and standardizing evaluation reports of Web-based and mobile health interventions. Journal of Medical Internet Research, 13(4), 1–10. doi:10.2196/jmir.1923

Fava, G. A., Rafanelli, C., Grandi, S., Conti, S., & Belluardo, P. (1998). Prevention of recurrent depression with cog-nitive behavioral therapy: preliminary findings. Archives of General Psychiatry, 55(9), 816–820. doi:10.1001/ archpsyc.55.9.816

Fava, A., Ruini, C., Rafanelli, C., Finos, L., Conti, S., & Grandi, S. (2004). Six-Year outcome of cognitive be-havior therapy for prevention of recurrent depression. American Journal of Psychiatry, 161(10), 1872–1876. doi:10.1176/ajp.161.10.1872

Fava, G. A. (2003). Can long-term treatment with antidepressant drugs worsen the course of depression? Journal of

Clinical Psychiatry, 64(2), 123–133. doi:10.4088/JCP.v64n0204

Fava, G. A. (2014). Rational use of antidepressant drugs. Psychotherapy and Psychosomatics, 83(4), 197–204. doi:10.1159/000362803

Fava, G. A. (2018). Time to rethink the approach to recurrent depression. The Lancet Psychiatry, 5(5), 380–381. doi:10.1016/S2215-0366(18)30128-7

Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015). Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review. Psychotherapy and Psychosomatics, 84(2), 72–81. doi:10.1159/000370338

Fava, G. A., & Offidani, E. (2011). The mechanisms of tolerance in antidepressant action. Progress in

Neuro-Psy-chopharmacology & Biological Psychiatry, 35(7), 1593–1602. doi:10.1016/j.pnpbp.2010.07.026

Fava, G. A., Rafanelli, C., Cazarro, M., Conti, S., & Grandi, S. (1998). Well-being therapy. A novel psychother-apeutic approach for residual symptoms of affective disorders. Psychological Medicine, 28(2), 475–480. doi:10.1017/S0033291797006363

Fawcett, J., Epstein, P., Fiester, S. J., Elkin, I., & Autry, J. H. (1987). Clinical management imipramine/placebo ad-ministration manual. NIMH Treatment of Depression Collaborative Research Program. Psychopharmacology

Bulletin, 23(2), 309–324.

Fenwick, E., O’Brien, B. J., & Briggs, A. (2004). Cost-effectiveness acceptability curves - facts, fallacies and fre-quently asked questions. Health Economics, 13(5), 405–415. doi:10.1002/hec.903

Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J., … Whiteford, H. A. (2013). Burden of depressive disorders by country, sex, age, and year: findings from the Global Burden of Disease Study 2010. PLoS Medicine, 10(11), 1–28. doi:10.1371/journal.pmed.1001547

Foundation of Pharmaceutical Statistics. (2014). Data en Feiten. Het jaar 2013 in cijfers. Retrieved from http:// www.sfk.nl.

Frank, E., Prien, R. F., Jarrett, R. B., Keller, M. B., Kupfer, D. J., Lavori, P. W., … Weissman, M. M. (1991). Concep-tualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry, 48(9), 851–855. doi:10.1001/archpsyc.1991.01810330075011 Fried, E. I. (2017). Moving forward: how depression heterogeneity hinders progress in treatment and research.

Expert Review of Neurotherapeutics, 17(5), 423–425. doi:10.1080/14737175.2017.1307737

Fried, E. I., & Nesse, R. M. (2015). Depression is not a consistent syndrome: an investigation of unique symptom patterns in the STAR∗D study. Journal of Affective Disorders, 172, 96–102. doi:10.1016/j.jad.2014.10.010 Friedberg, R. D., Viglione, D. J., Stinson, B. L., Beal, K. G., Fidaleo, R. A., & Celeste, B. (1999). Perceptions of

treatment helpfulness and depressive symptomatology in psychiatric inpatients on a cognitive therapy unit.

Journal of Rational-Emotive and Cognitive-Behavior Therapy, 17(1), 33–50. doi:10.1023/A:1023021114133

Friedrich, M. J. (2017). Depression is the leading cause of disability around the world. JAMA, 317(15), 1517. doi:10.1056/NEJMc1301373

(8)

prac-tical guide to probabilistic prognostic reasoning, 19(1), 10–15. doi:10.1136/eb-2015-102295

Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989). Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.

Journal of the National Cancer Institute, 81(24), 1879–1886. doi:10.1093/jnci/81.24.1879

Gauthier, G., Guérin, A., Zhdanava, M., Jacobson, W., Nomikos, G., Merikle, E., … Perez, V. (2017). Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major de-pressive disorder: a retrospective US claims database analysis. BMC Psychiatry, 17(1), 1–12. doi:10.1186/ s12888-017-1385-0

Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003). Re-lapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. The Lancet,

361(9358), 653–661. doi:10.1016/S0140-6736(03)12599-8

Geersing, G. J., Zuithoff, N. P., Kearon, C., Anderson, D. R., ten Cate-Hoek, A. J., Elf, J. L., … Moons, K. G. (2014). Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis. BMJ, 348(5), 1–13. doi:10.1136/bmj.g1340

Gerrits, M. M., van Oppen, P., Leone, S. S., van Marwijk, H. W., van der Horst, H. E., & Penninx, B. W. (2014). Pain, not chronic disease, is associated with the recurrence of depressive and anxiety disorders. BMC

Psychia-try, 14(187), 1–9. doi:10.1471-244X/14/187

GGZ Standaarden. (2018). Depressieve stoornissen. Retrieved from https://www.ggzstandaarden.nl/zorgstan-daarden/depressieve-stoornissen.

Ghosh, D., & Vogt, A. (2012). Outliers: an evaluation of methodologies. Joint Statistical Metings. San Diego CA: American Statistical Association.

Gibson, K., Cartwright, C., & Read, J. (2014). Patient-centered perspectives on antidepressant use: a narrative review. International Journal of Mental Health, 43(1), 81–99. doi:10.2753/IMH0020-7411430105

Glue, P., Donovan, M. R., Kolluri, S., & Emir, B. (2010). Meta-analysis of relapse prevention antidepres-sant trials in depressive disorders. Australian and New Zealand Journal of Psychiatry, 44(8), 697–705. doi:10.3109/00048671003705441

Godfrin, K. A., & van Heeringen, C. (2010). The effects of mindfulness-based cognitive therapy on recurrence of depressive episodes, mental health and quality of life: a randomized controlled study. Behaviour Research and

Therapy, 48(8), 738–746. doi:10.1016/j.brat.2010.04.006

Graham, J. W. (2009). Missing data analysis: making it work in the real world. Annual Review of Psychologyeview

of Psychology, 60, 549–576. doi:10.1146/annurev.psych.58.110405.085530

Greenberg, P. E., Fournier, A. A., Sisitsky, T., Pike, C. T., & Kessler, R. C. (2015). The economic burden of adults with major depressive disorder in the United States (2005 and 2010). The Journal of Clinical Psychiatry, 76(2), 155–162. doi:10.4088/JCP.14m09298

Groenwold, R. H., Moons, K. G., & Vandenbroucke, J. P. (2014). Randomized trials with missing outcome data: how to analyze and what to report. CMAJ, 186(15), 1153–1157. doi:10.1503/cmaj.131353

Groenwold, R. H., Moons, K. G., Pajouheshnia, R., Altman, D. G., Collins, G. S., Debray, T. P., … Peelen, L. M. (2016). Explicit inclusion of treatment in prognostic modeling was recommended in observational and ran-domized settings. Journal of Clinical Epidemiology, 78, 90–100. doi:10.1016/j.jclinepi.2016.03.017 Guidi, J., Fava, G. A., Fava, M., & Papakostas, G. I. (2011). Efficacy of the sequential integration of

psychothera-py and pharmacotherapsychothera-py in major depressive disorder: a preliminary meta-analysis. Psychological Medicine,

41(2), 321–331. doi:10.1017/S0033291710000826

Guidi, J., Tomba, E., & Fava, G. A. (2016). The sequential integration of pharmacotherapy and psychotherapy in the treatment of major depressive disorder: a meta-analysis of the sequential model and a critical review of the literature. American Journal of Psychiatry, 173(2), 128–137. doi:10.1176/appi.ajp.2015.15040476

Gustavsson, A., Svensson, M., Jacobi, F., Allgulander, C., Alonso, J., Beghi, E., … CDBE2010Study Group. (2011). Cost of disorders of the brain in Europe 2010. European Neuropsychopharmacology, 21(10), 718–779. doi:10.1016/j.euroneuro.2011.08.008

Hakkaart-van Roijen, L. (2002). Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness (TIC-P). Rotterdam, the Netherlands.

Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery & Psychiatry, 23, 56–62. doi:10.1136/jnnp.23.1.56

(9)

Neurotherapeu-tics, 7(1), 57–62. doi:10.1586/14737175.7.1.57

Hansson, M., Chotai, J., & Bodlund, O. (2012). What made me feel better? Patients’ own explanations for the improvement of their depression. Nordic Journal of Psychiatry, 66(4), 290–296. doi:10.3109/08039488.201 1.644807

Hardeveld, F., Spijker, J., de Graaf, R., Hendriks, S. M., Licht, C. M., Nolen, W. A., … Beekman, A. T. (2013). Recurrence of major depressive disorder across different treatment settings: results from the NESDA study.

Journal of Affective Disorders, 147(1–3), 225–231. doi:10.1016/j.jad.2012.11.008

Hardeveld, F., Spijker, J., de Graaf, R., Nolen, W. A., & Beekman, A. T. (2010). Prevalence and predictors of recur-rence of major depressive disorder in the adult population. Acta Psychiatrica Scandinavica, 122(3), 184–191. doi:10.1111/j.1600-0447.2009.01519.x

Hardeveld, F., Spijker, J., de Graaf, R., Nolen, W. A., & Beekman, A. T. F. (2013). Recurrence of major depressive disorder and its predictors in the general population: Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Psychological Medicine, 43(1), 39–48. doi:10.1017/S0033291712002395 Harrell, F. E. Jr., Lee, K. L., & Mark, D. B. (1996). Multivariable prognostic models: issues in developing

mod-els, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in Medicine, 15(4), 361–387. doi:10.1002/0470023678.ch2b(i)

Haybittle, J. L., Blamey, R. W., Elston, C. W., Johnson, J., Doyle, P. J., Campbell, F. C., … Griffiths, K. (1982). A prognostic index in primary breast cancer. British Journal of Cancer, 45(3), 361–366. doi:10.1038/bjc.1982.62 Hoertel, N., Blanco, C., Oquendo, M. A., Wall, M. M., Olfson, M., Falissard, B., … Limosin, F. (2017). A compre-hensive model of predictors of persistence and recurrence in adults with major depression: results from a nation-al 3-year prospective study. Journnation-al of Psychiatric Research, 95, 19–27. doi:10.1016/j.jpsychires.2017.07.022 Hoertel, N., Franco, S., Wall, M. M., Oquendo, M. A., Kerridge, B. T., Limosin, F., & Blanco, C. (2015). Mental

disorders and risk of suicide attempt: a national prospective study. Molecular Psychiatry, 20(6), 718–726. doi:10.1038/mp.2015.19

Holländare, F., A. Anthony, S. A., Randestad, M., Tillfors, M., Carlbring, P., Andersson, G., & Engström, I. (2013). Two-year outcome of internet-based relapse prevention for partially remitted depression. Behaviour Research

and Therapy, 51(11), 719–722. doi:10.1016/j.brat.2013.08.002

Holländare, F., Johnsson, S., Randestad, M., Tillfors, M., Carlbring, P., Andersson, G., & Engström, I. (2011). Ran-domized trial of Internet-based relapse prevention for partially remitted depression. Acta Psychiatrica

Scandi-navica, 124(4), 285–294. doi:10.1111/j.1600-0447.2011.01698.x

Holma, K. M., Holma, I. A., Melartin, T. K., Rytsala, H. J., & Isometsa, E. T. (2008). Long-term outcome of major depressive disorder in psychiatric patients is variable. J Clin Psychiatry, 69(2), 196–205. doi:ej06m02918 [pii] Horne, R., Chapman, S. C., Parham, R., Freemantle, N., Forbes, A., & Cooper, V. (2013). Understanding patients’

adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS ONE, 8(12). doi:10.1371/journal.pone.0080633

Hovens, J. G., Giltay, E. J., Spinhoven, P., van Hemert, A. M., & Penninx, B. W. (2015). Impact of childhood life events and childhood trauma on the onset and recurrence of depressive and anxiety disorders. Journal of

Clin-ical Psychiatry, 76(7), 931–938. doi:10.1111/j.1600-0447.2011.01828.x

Hovens, J. G., Giltay, E. J., Wiersma, J. E., Spinhoven, P., Penninx, B. W., & Zitman, F. G. (2012). Impact of child-hood life events and trauma on the course of depressive and anxiety disorders. Acta Psychiatrica Scandinavica,

126(3), 198–207. doi:10.1111/j.1600-0447.2011.01828.x

Huijbers, M. J., Spinhoven, P., Spijker, J., Ruhé, H. G., van Schaik, D. J. F., van Oppen, P., … Speckens, A. E. (2015). Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: randomised controlled trial. Journal of Affective Disorders,

187, 54–61. doi:10.1016/j.jad.2015.08.023

Huijbers, M. J., Spinhoven, P., Spijker, J., Ruhé, H. G., van Schaik, D. J. F., van Oppen, P., … Speckens, A. E. (2016). Discontinuation of antidepressant medication after mindfulness-based cognitive therapy for recurrent depression: randomised controlled non-inferiority trial. The British Journal of Psychiatry, 208(4), 366–373. doi:10.1192/bjp.bp.115.168971

Hung, C. I. (2014). Factors predicting adherence to antidepressant treatment. Current Opinion in Psychiatry, 27(5), 344–349. doi:10.1097/YCO.0000000000000086

Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., … CHEERS Task Force. (2013). Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Value Health, 16(2),

(10)

e1–5. doi:10.1016/j.jval.2013.02.010

Iniesta, R., Stahl, D., & McGuffin, P. (2016). Machine learning, statistical learning and the future of biological research in psychiatry. Psychological Medicine, 46(12), 2455–2465. doi:10.1017/S0033291716001367 Johansson, R., & Andersson, G. (2012). Internet-based psychological treatments for depression. Expert Review of

Neurotherapeutics, 12(7), 861–870. doi:10.1586/ern.12.63

Johnston, B. J. (2013). The role of patient experience and its influence on adherence to antidepressant treat-ment. Journal of Psychosocial Nursing and Mental Health Services, 51(12), 29–37. doi:10.3928/02793695-20130930-04

Jorm, A. F., Christensen, H., Medway, J., Korten, A. E., Jacomb, P. A., & Rodgers, B. (2000). Public belief systems about the helpfulness of interventions for depression: associations with history of depression and professional help- seeking. Social Psychiatry and Psychiatric Epidemiology, 35(5), 211–219. doi:10.1007/s001270050230 Judd, L. (1997). The clinical course of unipolar major depressive disorders. Archives of General Psychiatry, 54(11),

989–991. doi:10.1001/archpsyc.1997.01830230015002

Judd, L. L., Schettler, P. J., & Rush, A. J. (2016). A brief clinical tool to estimate individual patients’ risk of de-pressive relapse following remission: proof of concept. American Journal of Psychiatry, 173(11), 1140–1146. doi:10.1176/appi.ajp.2016.15111462

Jureidini, J., & Tonkin, A. (2006). Overuse of antidepressant drugs for the treatment of depression. CNS Drugs,

20(8), 623–632. doi:10.2165/00023210-200620080-00002

Kaltenthaler, E., Brazier, J., de Nigris, E., Tumur, I., Ferriter, M., Beverley, C., … Sutcliffe, P. (2006). Computerised cognitive behaviour therapy for depression and anxiety update: a systematic review and economic evaluaton,

Health Technology Assessment, 10(33), 1–168. doi:10.3310/hta10339

Kang, H. J., Kim, S. Y., Bae, K. Y., Kim, S. W., Shin, I. S., Yoon, J. S., & Kim, J. M. (2015). Comorbidity of de-pression with physical disorders : research and clinical implications. Chonnam Medical Journal, 51(1), 8–18. doi:10.4068/cmj.2015.51.1.8

Karyotaki, E., Daniel, D. D., Donkin, L., Riper, H., Twisk, J., Burger, S., … Cuijpers, P. (2018). Do guided inter-net-based interventions result in clinically relevant changes for patients with depression? An individual partici-pant data meta-analysis. Clinical Psychology Review, 63, 80–92. doi:10.1016/j.cpr.2018.06.007

Karyotaki, E., Riper, H., Twisk, J., Hoogendoorn, A., Kleiboer, A., Mira, A., … Cuijpers, P. (2017). Efficacy of self-guided Internet-based cognitive behavioral therapy in the treatment of depressive symptoms: a me-ta-analysis of individual participant data. JAMA Psychiatry, 74(4), 351–359. doi:10.1001/JAMAPSYCHIA-TRY.2017.0044

Karyotaki, E., Tordrup, D., Buntrock, C., Bertollini, R., & Cuijpers, P. (2017). Economic evidence for the clinical management of major depressive disorder: a systematic review and quality appraisal of economic evaluations alongaside randomised controlled trials. Epidemiology and Psychiatric Sciences, 26(5), 501–516. doi:10.1017/ S2045796016000421

Kathol, R. G., & Petty, F. (1981). Relationship of depression to medical illness. A critical review. Journal of

Affec-tive Disorders, 3(2), 111–121. doi:10.1503/jpn.150099

Katon, W. J. (2011). Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues

in Clinical Neuroscience, 13(1), 7–23.

Katz, G. (2011). Tachyphylaxis/ tolerance to antidepressive medications: a review. Israel Journal of Psychiatry and

Related Sciences, 48(2), 129–135.

Kaymaz, N., van Os, J., Loonen, A. J. M., & Nolen, W. A. (2008). Evidence that patients with single versus re-current depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of place-bo-controlled randomized trials. Journal of Clinical Psychiatry, 69(9), 1423–1436. doi:10.4088/JCP.v69n0910 Kennedy, J. C., Dunlop, B. W., Craighead, L. W., Nemeroff, C. B., Mayberg, H. S., & Craighead, W. E. (2018). Fol-low-up of monotherapy remitters in the PReDICT study: maintenance treatment outcomes and clinical predic-tors of recurrence. Journal of Consulting and Clinical Psychology, 86(2), 189–199. doi:10.1037/ccp0000279 Kennedy, S. H. (2006). A review of antidepressant treatments today. European Neuropsychopharmacology,

16(Sup-plement 5), S619–S624. doi:10.1016/S0924-977X(06)70007-4

Kessler, R. C., van Loo, H. M., Wardenaar, K. J., Bossarte, R. M., Brenner, L. A., Ebert, D. D., … Zaslavsky, A. M. (2017). Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder.

Epidemiology and Psychiatric Sciences, 26(1), 22–36. doi:10.1017/S2045796016000020

(11)

(2017). Testing a machine-learning algorithm to predict the persistence and severity of major depressive disor-der from baseline self- reports. Molecular Psychiatry, 21(10), 1366–1371. doi:10.1038/mp.2015.198 Khalsa, S. R., Mccarthy, K. S., Sharpless, B. A., Barrett, M. S., & Barber, J. P. (2011). Beliefs about the causes of

depression and treatment preferences. Journal of Clinical Psychology, 67(6), 539–549. doi:10.1002/jclp.20785 King, M., Bottomley, C., Bellón-Saameño, J., Torres-Gonzalez, F., Svab, I., Rotar, D., … Nazareth, I. (2013).

Predicting onset of major depression in general practice attendees in Europe: extending the application of the predictD risk algorithm from 12 to 24 months. Psychological Medicine, 43(09), 1929–1939. doi:10.1017/ S0033291712002693

King, M., Walker, C., Levy, G., Bottomley, C., Royston, P., Weich, S., … Nazareth, I. (2008). Development and validation of an international risk prediction algorithm for episodes of major depression in general practice attendees. Archives of General Psychiatry, 65(12), 1368–1376. doi:10.1001/archpsyc.65.12.1368s

Kleiboer, A., Donker, T., Seekles, W., van Straten, A., Riper, H., & Cuijpers, P. (2015). A randomized controlled trial on the role of support in Internet-based problem solving therapy for depression and anxiety. Behaviour

Research and Therapy, 72, 63–71. doi:10.1016/j.brat.2015.06.013

Klein, N. S., Kok, G. D., Burger, H., van Valen, E., Riper, H., Cuijpers, P., … Bockting, C. L. H. (2018). No sustainable effects of an internet-based relapse prevention program over 24 months in recurrent depres-sion: primary outcomes of a randomized controlled trial. Psychotherapy and Psychosomatics, 87(1), 55–57. doi:10.1159/000485039

Kohn, R., Saxena, S., Levav, I., & Saraceno, B. (2004). The treatment gap in mental health care. Bulletin of the

World Health Organization, 82(11), 858–866. doi:/S0042-96862004001100011

Kok, G. D., Bockting, C. L. H., Burger, H., Hannig, W., Pijnenborg, G. H. M., Cuijpers, P., & Hollon, S. D. (2013). Double trouble: Does co-morbid chronic somatic illness increase risk for recurrence in depression? A system-atic review. PLoS ONE, 8(3), 1–7. doi:10.1371/journal.pone.0057510

Kok, G. D., Burger, H., Riper, H., Cuijpers, P., Dekker, J., van Marwijk, H., … Bockting, C. L. H. (2015). The three-month effect of mobile Internet-based cognitive therapy on the course of depressive symptoms in remitted recurrently depressed patients: results of a randomized controlled trial. Psychotherapy and Psychosomatics,

84(2), 90–99. doi:10.1159/000369469

Kolovos, S., van Dongen, J. M., Riper, H., Buntrock, C., Cuijpers, P., Ebert, D. D., … Bosmans, J. E. (2018). Cost effectiveness of guided Internet-based interventions for depression in comparison with control conditions: an individual-participant data meta-analysis. Depression and Anxiety, 35(3), 209–219. doi:10.1002/da.22714 Koopmanschap, M. A., Rutten, F. F. H., van Ineveld, B. M., & van Roijen, L. (1995). The friction cost method

for measuring indirect costs of disease. Journal of Health Economics, 14(2), 171–189. doi:10.1016/0167-6296(94)00044-5

Kordy, H., Wolf, M., Aulich, K., Bürgy, M., Hegerl, U., Hüsing, J., … Backenstrass, M. (2016). Internet-delivered disease management for recurrent depression: a multicenter randomized controlled trial. Psychotherapy and

Psychosomatics, 85(2), 91–98. doi:10.1159/000441951

Kraaij, V., & de Wilde, E. J. (2001). Negative life events and depressive symptoms in the elderly: a life span per-spective, Aging & Mental Health, 5(1), 84–91. doi:10.1080/13607860020020681

Krol, M., Brouwer, W., & Rutten, F. (2013). Productivity costs in economic evaluations: past, present, future.

Phar-macoEconomics, 31(7), 537–549. doi:10.1007/s40273-013-0056-3

Krol, M., Papenburg, J., Koopmanschap, M., & Brouwer, W. (2011). Do productivity costs matter?: the impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders.

Phar-macoEconomics, 29(7), 601–619. doi:10.2165/11539970-000000000-00000

Kuehner, C., & Huffziger, S. (2013). Factors predicting the long-term illness course in a cohort of depressed inpa-tients. Eur Arch Psychiatry Clin Neurosci., 263(5), 413–423. doi:10.1007/s00406-012-0379-7

Kuyken, W., Byford, S., Taylor, R. S., Watkins, E., Holden, E., White, K., … Teasdale, J. D. (2008). Mindful-ness-based cognitive therapy to prevent relapse in recurrent depression. Journal of Consulting and Clinical

Psychology, 76(6), 966–978. doi:10.1037/a0013786

Kuyken, W., Warren, F. C., Taylor, R. S., Whalley, B., Crane, C., Bondolfi, G., … Dalgleish, T. (2016). Efficacy of mindfulness-based cognitive therapy in prevention of depressive relapse. An individual patient data meta-anal-ysis from randomized trials. Jamapsychiatry, 73(6), 1–24. doi:10.1001/jamapsychiatry.2016.0076

Kuyken, W., Hayes, R., Barrett, B., Byng, R., Dalgleish, T., Kessler, D., … Byford, S. (2015). Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant

(12)

treat-ment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. The

Lancet, 386(9988), 63–73. doi:10.1016/S0140-6736(14)62222-4

Lamers, L. M., McDonnell, J., Stalmeier, P. F., Krabbe, P. F., & Busschbach, J. J. (2006). The Dutch tariff: re-sults and arguments for an effective design for national EQ-5D valuation studies. Health Economics, 15(10), 1121–1132. doi:10.1002/hec

Leydon, G. M., Rodgers, L., & Kendrick, T. (2007). A qualitative study of patient views on discontinuing long-term selective serotonin reuptake inhibitors. Family Practice, 24(6), 570–575. doi:10.1093/fampra/cmm069 Li, K-H., Meng, X-L., Raghunathan, T. E., & Rubin, D. B. (1991). Significance levels from repeated p-values with

multiply-imputed data. Statistica Sinica, 1(1), 65-92.

Lingam, R., & Scott, J. (2002). Treatment non-adherence in affective disorders. Acta Psychiatrica Scandinavica,

105(3), 164–172. doi:10.1034/j.1600-0447.2002.1r084.x

Lloyd-Jones, D. M. (2010). Cardiovascular risk prediction: basic concepts, current status, and future directions.

Circulation, 121(15), 1768–1777. doi:10.1161/CIRCULATIONAHA.109.849166

Lok, A., Bockting, C. L. H., Koeter, M. W. J., Snieder, H., Assies, J., Mocking, R. J. T., … Schene, A. H. (2013). Interaction between the MTHFR C677T polymorphism and traumatic childhood events predicts depression.

Translational Psychiatry, 3(7), 1–8. doi:10.1038/tp.2013.60

Lokkerbol, J., Adema, D., Cuijpers, P., Reynolds, C. F., Schulz, R., Weehuizen, R., & Smit, F. (2014). Improv-ing the cost-effectiveness of a healthcare system for depressive disorders by implementImprov-ing telemedicine: a health economic modeling study. American Journal of Geriatric Psychiatry, 22(3), 253–262. doi:10.1016/j. jagp.2013.01.058

Lopez-Munoz, F., & Alamo, C. (2009). Monoaminergic neurotransmission: the history of the discov-ery of antidepressants from 1950s until today. Current Pharmaceutical Design, 15(14), 1563–1586. doi:10.2174/138161209788168001

Löwe, B., Schulz, U., Gräfe, K., & Wilke, S. (2006). Medical patients’ attitudes toward emotional problems and their treatment: what do they really want? Journal of General Internal Medicine, 21(1), 39–45. doi:10.1111/ j.1525-1497.2005.0266.x

Luppa, M., Heinrich, S., Angermeyer, M. C., König, H. H., & Riedel-Heller, S. G. (2007). Cost-of-illness studies of depression. Journal of Affective Disorders, 98(1–2), 29–43. doi:10.1016/j.jad.2006.07.017

Lynch, J., Moore, M., Moss-Morris, R., & Kendrick, T. (2015). Do patients’ illness beliefs predict depression measures at six months in primary care; a longitudinal study. Journal of Affective Disorders, 174, 665–671. doi:10.1016/j.jad.2014.12.005

Ma, S. H., & Teasdale, J. D. (2004). Mindfulness-based cognitive therapy for depression: replication and explora-tion of differential relapse prevenexplora-tion effects. Journal of Consulting and Clinical Psychology, 72(1), 31–40. doi:10.1037/0022-006X.72.1.31

Manca, A., & Palmer, S. (2005). Handling missing data in patient-level cost-effectiveness analysis alongside ran-domised clinical trials, Applied Health Economics and Health Policy, 4(2), 65–75. doi:10.2165/00148365-200504020-00001

Marshall, A., Altman, D. G., Holder, R. L., & Royston, P. (2009). Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines. BMC Medical Research

Method-ology, 9(1), 1–8. doi:10.1186/1471-2288-9-57

Mathers, C. D., & Loncar, D. (2006). Projections of global mortality and burden of disease from 2002 to 2030.

PLOS Medicine, 3(11), 2011–2030. doi:10.1371/journal.pmed.0030442

McHugh, R. K., Whitton, S. W., Peckham, A. D., Welge, J. A., & Otto, M. W. (2013). Patient preference for psy-chological vs. pharmacological treatment of psychiatric disorders: a meta-analytic review. Journal of Clinical

Psychology, 74(6), 595–602. doi:10.4088/JCP.12r07757

Meijer, W. E., Heerdink, E. R., Leufken, H. G., Herings, R. M., Egberts, A. C., & Nolen, W. A. (2004). Incidence and determinants of long-term use of antidepressants. European Journal of Clinical Pharmacology, 60(1), 57–61. doi:10.1007/s00228-004-0726-3

Moleman, P. (2009). Praktische psychofarmacologie. Houten, the Netherlands: Prelum.

Monroe, S. M. (2010). Recurrence in major depression: assessing risk indicators in the context of risk estimates. In C. S. Richards & M. G. Perri (Eds.), Relapse prevention for depression (pp. 27–49). Washington D.C.: Amer-ican Psychological Association.

(13)

and impact of prognostic models in clinical practice. BMJ, 338(7709), 1487–1490. doi:10.1136/bmj.b606 Morisky, D. E., Green, L. W., & Levine, D. M. (1986). Concurrent and predictive validity of a self-reported measure

of medication adherence. Medical Care, 24(1), 67–74. doi:10.1097/00005650-198601000-00007

Mueller, T. I., Leon, A. C., Keller, M. B., Solomon, D. A., Endicott, J., Coryell, W., … Maser, J. D. (1999). Recur-rence after recovery from major depressive disorder during 15 years of observational follow-up. The American

Journal of Psychiatry, 156(7), 1000–1006. doi:10.1176/ajp.156.7.1000

Mulder, R. (2015). Depression relapse: importance of a long-term perspective. The Lancet, 386(9988), 10–12. doi:10.1016/S0140-6736(14)62448-X

Musliner, K. L., Munk-Olsen, T., Eaton, W. W., & Zandi, P. P. (2016). Heterogeneity in long-term trajectories of depressive symptoms: patterns, predictors and outcomes. Journal of Affective Disorders, 192, 199–211. doi:10.1016/j.cogdev.2010.08.003

Nanni, V., Uher, R., & Danese, A. (2012). Childhood maltreatment predicts unfavorable course of illness and treat-ment outcome in depression: a meta-analysis. American Journal of Psychiatry, 169(2), 141–151. doi:10.1176. appi.ajp.2011.11020335

National Institute for Health and Care Excellence. (2009). Depression in adults: recognition and management

(update). Clinical guideline 90. Retrieved from https://www.nice.org.uk/guidance/cg90.

National Institute for Health and Care Excellence. (2010). Depression in adults with a chronic physical health

prob-lem. Treatment and management. NICE clinical guidelines, No. 91. Leicester: British Psychological Society.

National Institute for Health and Clinical Excellence. (2013). Guide to the methods of technology appraisal.

Pro-cess and Methods [PMG 9]. Retrieved from https://www.nice.org.uk/proPro-cess/pmg9/chapter/foreword.

Nelson, J., Klumparendt, A., Doebler, P., & Ehring, T. (2017). Childhood maltreatment and characteristics of adult depression: meta-analysis. British Journal of Psychiatry, 210(2), 96–104. doi:10.1192/bjp.bp.115.180752 Olbert, C. M., Gala, G. J., & Tupler, L. A. (2014). Quantifying heterogeneity attributable to polythetic diagnostic

criteria: theoretical framework and empirical application. Journal of Abnormal Psychology, 123(2), 452–462. doi:10.1037/a0036068

Olesen, J., Gustavsson, A., Svensson, M., Wittchen, H. U., Jönsson, B., CDBE2010 study Group., & Europe-an Brain Council. (2012). The economic cost of brain disorders in Europe. EuropeEurope-an Journal of Neurology,

19(1), 155–162. doi:10.1111/j.1468-1331.2011.03590.x

Olfson, M., Blanco, C., & Marcus, S. C. (2016). Treatment of adult depression in the United States. JAMA Internal

Medicine, 176(10), 1482–1491. doi:10.1001/jamainternmed.2016.5057

Ormel, J., Petukhova, M., Chatterji, S., Aguilar-Gaxiola, S., Alonso, J., Angermeyer, M. C., … Kessler, R. C. (2008). Disability and treatment of specific mental and physical disorders across the world. British Journal of

Psychiatry, 192(5), 368–375. doi:10.1192/bjp.bp.107.039107

Paganini, S., Teigelkötter, W., Buntrock, C., & Baumeister, H. (2018). Economic evaluations of internet- and mo-bile-based interventions for the treatment and prevention of depression: a systematic review. Journal of

Affec-tive Disorders, 225, 733–755. doi:10.1016/j.jad.2017.07.018

Pampallona, S., Bollini, P., Tibaldi, G., Kupelnick, B., & Munizza, C. (2002). Patient adherence in the treatment of depression. The British Journal of Psychiatry, 180(2), 104–109. doi:10.1192/bjp.180.2.104

Paterniti, S., Sterner, I., Caldwell, C., & Bisserbe, J. C. (2017). Childhood neglect predicts the course of major depression in a tertiary care sample: a follow-up study. BMC Psychiatry, 17(1), 1–13. doi:10.1186/s12888-017-1270-x

Peduzzi, P., Concato, J., Feinstein, A. R., & Holford, T. R. (1995). Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. Journal of

Clinical Epidemiology, 48(12), 1503–1510. doi:10.1016/0895-4356(95)00048-8

Piet, J., & Hougaard, E. (2011). The effect of mindfulness-based cognitive therapy for prevention of relapse in re-current major depressive disorder: a systematic review and meta-analysis. Clinical Psychology Review, 31(6), 1032–1040. doi:10.1016/j.cpr.2011.05.002

Pilkington, P. D., Reavley, N. J., & Jorm, A. F. (2013). The Australian public’s beliefs about the causes of de-pression: associated factors and changes over 16 years. Journal of Affective Disorders, 150(2), 356–362. doi:10.1016/j.jad.2013.04.019

Pompili, M., Venturini, P., Palermo, M., Stefani, H., Seretti, M. E., Lamis, D. A., … Girardi, P. (2013). Mood dis-orders medications: predictors of nonadherence. Review of the current literature. Expert Review of

(14)

Prins, M. A., Verhaak, P. F., Bensing, J. M., & van der Meer, K. (2008). Health beliefs and perceived need for mental health care of anxiety and depression-- the patients’ perspective explored. Clinical Psychology Review, 28(6), 1038–1058. doi:10.1016/j.cpr.2008.02.009

Prukkanone, B., Vos, T., Bertram, M., & Lim, S. (2012). Cost-effectiveness analysis for antidepressants and cogni-tive behavioral therapy for major depression in Thailand. Value in Health, 15(1 suppl), S3–S8. doi:10.1016/j. jval.2011.11.009

Rabin, R., & de Charro, F. (2001). EQ-5D: a measure of health status from the EuroQol Group. Annals of Medicine,

33(5), 337–343. doi:10.3109/07853890109002087

Read, J., Cartwright, C., Gibson, K., Shiels, C., & Haslam, N. (2014). Beliefs of people taking antidepressants about causes of depression and reasons for increased prescribing rates. Journal of Affective Disorders, 168, 236–242. doi:10.1016/j.jad.2014.06.010

Read, J., Cartwright, C., Gibson, K., Shiels, C., & Magliano, L. (2015). Beliefs of people taking antidepres-sants about the causes of their own depression. Journal of Affective Disorders, 174, 150–156. doi:10.1016/j. jad.2014.11.009

Redelmeier, D. A., & Dickinson, V. M. (2011). Determining whether a patient is feeling better: pitfalls from the science of human perception. Journal of General Internal Medicine, 26(8), 900–906. doi:10.1007/s11606-011-1655-3

Richards, D. (2011). Prevalence and clinical course of depression: a review. Clinical Psychology Review, 31(7), 1117–1125. doi:10.1016/j.cpr.2011.07.004

Richards, D., & Richardson, T. (2012). Computer-based psychological treatments for depression: a systematic re-view and meta-analysis. Clinical Psychology Rere-view, 32(4), 329–342. doi:10.1016/j.cpr.2012.02.004 Rijksoverheid. (2018). Publiekscampagne omgaan met depressie. Retrieved from

https://www.omgaanmetdepres-sie.nl/documenten/publicaties/2016/09/23/publiekscampagne-omgaan-met-depressie.

Roca, M., Armengol, S., García-García, M., Rodriguez-Bayón, A., Ballesta, I., Serrano, M. J., … Gili, M. (2011). Clinical differences between first and recurrent episodes in depressive patients. Comprehensive Psychiatry,

52(1), 26–32. doi:10.1016/j.comppsych.2010.04.011

Rodin, G., & Voshart, K. (1986). Depression in the medically ill: an overview. American Journal of Psychiatry,

143(6), 696–705. doi:10.1176/ajp.143.6.696

Rost, T., Stein, J., Löbner, M., Kersting, A., Luck-Sikorski, C., & Riedel-Heller, S. G. (2017). User acceptance of computerized Cognitive Behavioral Therapy for depression: systematic review. Journal of Medical Internet

Research, 19(9), e309. doi:10.2196/jmir.7662

Royston, P., & Altman, D. G. (2013). External validation of a Cox prognostic model: principles and methods. BMC

Medical Research Methodology, 13(33), 1–15. doi:10.1186/1471-2288-13-33

Rubin, D. (1987). Multiple Imputation for Nonresponse in Surveys. New York: John Wiley & Sons.

Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996). The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychological Medicine, 26(3), 477–486. doi:10.1017/ S0033291700035558

Rush, A. J., Kraemer, H. C., Sackeim, H. A., Fava, M., Trivedi, M. H., Frank, E., … ACNP Task Force. (2006). Report by the ACNP Task Force on response and remission in major depressive disorder.

Neuropsychophar-macology, 31(9), 1841–1853. doi:10.1038/sj.npp.1301131

Sansone, R. A., & Sansone, L. A. (2012). Antidepressant adherence: are patients taking their medications?

Innova-tions in Clinical Neuroscience, 9(5–6), 41–46.

Saxena, S., Thornicroft, G., Knapp, M., & Whiteford, H. (2007). Resources for mental health: scarcity, inequity, and inefficiency. The Lancet, 370(9590), 878–889. doi:10.1016/S0140-6736(07)61239-2

Schafer, J. L., & Graham, J. W. (2002). Missing data: our view of the state of the art. Psychological Methods, 7(2), 147–177. doi:10.1037//1082-989X.7.2.147

Scott, J., Palmer, S., Paykel, E., Teasdale, J., & Hayhurst, H. (2003). Use of cognitive therapy for relapse preven-tion in chronic depression: cost-effectiveness study. British Journal of Psychiatry, 182, 221–227. doi:10.1192/ bjp.02.342

Segal, Z. V, Bieling, P., Young, T., MacQueen, G., Cooke, R., Martin, L., … Levitan, R. D. (2010). Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression. Archives of General Psychiatry, 67(12), 1256–1264. doi:10.1001/arch-genpsychiatry.2010.168

(15)

Shimodera, S., Furukawa, T. A., Mino, Y., Shimazu, K., Nishida, A., & Inoue, S. (2012). Cost-effectiveness of fam-ily psychoeducation to prevent relapse in major depression: results from a randomized controlled trial. BMC

Psychiatry, 12(40), 1-6. doi:10.1186/1471-244X-12-40

Skodol, A. E., Grilo, C. M., Keyes, K. M., Geier, T., Grant, B. F., & Hasin, D. S. (2011). Relationship of personality disorders to the course of major depressive disorder in a nationally representative sample. American Journal of

Psychiatry, 168(3), 257–264. doi:10.1176/appi.ajp.2010.10050695

So, M., Yamaguchi, S., Hashimoto, S., Sado, M., Furukawa, T. A., & McCrone, P. (2013). Is computerised CBT real-ly helpful for adult depression? A meta-anareal-lytic re-evaluation of CCBT for adult depression in terms of clinical implementation and methodological validity. BMC Psychiatry, 13(1), 1–14. doi:10.1186/1471-244X-13-113 Solomon, D. A., Keller, M. B., Leon, A. C., Mueller, T. I., Lavori, P. W., Shea, M. T., … Endicott, J. (2000). Multiple

recurrences of major depressive disorder. The American Journal of Psychiatry, 157(2), 229–233. doi:10.1176/ appi.ajp.157.2.229

Spek, V., Cuijpers, P., Nyklícek, I., Riper, H., Keyzer, J., & Pop, V. (2007). Internet-based cognitive behaviour therapy for symptoms of depression and anxiety: a meta-analysis. Psychological Medicine, 37(3), 319–328. doi:10.1017/S0033291706008944

Spijker, J., Bockting, C. L. H., Meeuwissen, J. A. C., van Vliet, I. M., Emmelkamp, P. M. G., Hermens, M. L. M., & van Balkom, A. J. L. M. (2013). Multidisciplinaire Richtlijn Depressie (Derde revisie). Richtlijn voor

de diagnostiek, behandeling en begeleiding van volwassen patiënten met een depressieve stoornis. Utrecht:

Trimbos-instituut.

Spijker, J., de Graaf, R., Ormel, J., Nolen, W. A., Grobbee, D. E., & Burger, H. (2006). The persistence of depres-sion score. Acta Psychiatrica Scandinavica, 144(6), 411–416. doi:10.1111/j.1600-0447.2006.00821.x Spitzer, R. L., Williams, J. B., Gibbon, M., & First, M. B. (1992). The Structured Clinical Interview for DSM-III—R

(SCID). I. History, rationale, and description. Archives of General Psychiatry, 49(8), 624–629. doi:10.1001/ archpsyc.1992.01820080032005

Stangier, U., Hilling, C., Heidenreich, T., Risch, A. K., Barocka, A., Schlösser, R., … Hautzinger, M. (2013). Maintenance cognitive-behavioral therapy and manualized psychoeducation in the treatment of recurrent de-pression: a multicenter prospective randomized controlled trial. The American Journal of Psychiatry, 170(6), 624–632. doi:10.1176/appi.ajp.2013.12060734

Steyerberg, E. W., Moons, K. G. M., van der Windt, D. A., Hayden, J. A., Perel, P., Schroter, S., … PROG-RESS Group. (2013). Prognosis Research Strategy (PROGPROG-RESS) 3: prognostic model research. PLoS

Medi-cine, 10(2), 1–29. doi:10.1371/journal.pmed.1001381

Stroud, C. B., Davila, J., & Moyer, A. (2008). The relationship between stress and depression in first onsets versus recurrences: a meta-analytic review. Journal of Abnormal Psychology, 117(1), 206–213. doi:10.1037/0021-843X.117.1.206

Sullivan, M. D., Katon, W. J., Russo, J. E., Frank, E., Barrett, J. E., Oxman, T. E., & Williams, J. W. jr. (2003). Pa-tient beliefs predict response to paroxetine among primary care paPa-tients with dysthymia and minor depression.

The Journal of the American Board of Family Practice, 16(1), 22–31. doi:10.3122/jabfm.16.1.22

Teasdale, J. D., Segal, Z. V, Williams, J. M., Ridgeway, V. A., Soulsby, J. M., & Lau, M. A. (2000). Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Journal of Consulting and

Clinical Psychology, 68(4), 615–623. doi:10.1037/0022-006X.68.4.615

ten Doesschate, M. C., Bockting, C. L. H., Koeter, M. W., & Schene, A. H. (2009). Predictors of nonadherence to continuation and maintenance antidepressant medication in patients with remitted recurrent depression.

Jour-nal of Clinical Psychiatry, 70(1), 63–69. doi:10.4088/JCP.08m04119

ten Doesschate, M. C., Bockting, C. L. H., Koeter, M. W., & Schene, A. H. (2010). Prediction of recurrence in re-current depression: a 5.5-year prospective study. Journal of Clinical Psychiatry, 71(8), 984–991. doi:10.4088/ JCP.08m04858blu

ten Haaf, K., Jeon, J., Tammemägi, M. C., Han, S. S., Kong, C. Y., Plevritis, S. K., … Meza, R. (2017). Risk predic-tion models for selecpredic-tion of lung cancer screening candidates: a retrospective validapredic-tion study. PLOS Medicine,

14(4), 1–36. doi:10.1371/journal.pmed.1002277

ten Have, M., de Graaf, R., van Dorsselaer, S., Tuithof, M., Kleinjan, M., & Penninx, B. W. J. H. (2018). Recurrence and chronicity of major depressive disorder and their risk indicators in a population cohort. Acta Psychiatrica

Scandinavica, 137(7), 1–13. doi:10.1111/acps.12874

(16)

attribution rules. Inquiry, 43(3), 271–282. doi:10.5034/inquiryjrnl

Thornicroft, G., Deb, T., & Henderson, C. (2016). Community mental health care worldwide: current status and further developments. World Psychiatry, 15(3), 276–286. doi:10.1002/wps.20349

Tiffin, P. A., & Paton, L. W. (2018). Rise of the machines? Machine learning approaches and mental health: oppor-tunities and challenges. The British Journal of Psychiatry, 213(3), 509–510. doi:10.1192/bjp.2018.105 Tran, T., Luo, W., Phung, D., Harvey, R., Berk, M., Kennedy, R. L., & Venkatesh, S. (2014). Risk stratification using

data from electronic medical records better predicts suicide risks than clinician assessments. BMC Psychiatry,

14(1), 1–20. doi:10.1186/1471-244X-14-76

Uzun, S., Kozumplik, O., Topić, R., & Jakovljevi, M. (2009). Depressive disorders and comorbidity: somatic illness vs. side effect. Psychiatria Danubina, 21(3), 391–398.

van Ballegooijen, W., Cuijpers, P., van Straten, A., Karyotaki, E., Andersson, G., Smit, J. H., & Riper, H. (2014). Adherence to internet-based and face-to-face cognitive behavioural therapy for depression: a meta-analysis.

PLoS ONE, 9(7), 1–11. doi:10.1371/journal.pone.0100674

van Calster, B., Nieboer, D., Vergouwe, Y., de Cock, B., Pencina, M. J., & Steyerberg, E. W. (2016). A calibration hierarchy for risk models was defined: from utopia to empirical data. Journal of Clinical Epidemiology, 74, 167–176. doi:10.1016/j.jclinepi.2015.12.005

van Diepen, M., Ramspek, C. L., Jager, K. J., Zoccali, C., & Dekker, F. W. (2017). Prediction versus aetiology: com-mon pitfalls and how to avoid them. Nephrology Dialysis Transplantation, 32(suppl_2), ii1-ii5. doi:10.1093/ ndt/gfw459

van Loo, H. M., Aggen, S. H., Gardner, C. O., & Kendler, K. S. (2015). Multiple risk factors predict recurrence of major depressive disorder in women. Journal of Affective Disorders, 180, 52–61. doi:10.1016/j.jad.2015.03.045 van Schaik, D. J. F., Klijn, A. F. J., van Hout, H. P. J., van Marwijk, H. W. J., Beekman, A. T. F., de Haan, M., &

van Dyck, R. (2004). Patients’ preferences in the treatment of depressive disorder in primary care. General

Hospital Psychiatry, 26(3), 184–189. doi:10.1016/j.genhosppsych.2003.12.001

Verbeek-Heida, P. M., & Mathot, E. F. (2006). Better safe than sorry--why patients prefer to stop using selective se-rotonin reuptake inhibitor (SSRI) antidepressants but are afraid to do so: results of a qualitative study. Chronic

Illness, 2(2), 133–142. doi:10.1179/174592006X111003

Viguera, A. C., Baldessarini, R. J., & Friedberg, J. (1998). Discontinuing antidepressant treatment in major depres-sion. Harvard Review of Psychiatry, 5(6), 293–306. doi:10.3109/10673229809003578

Vittengl, J. R., Clark, L. A., Dunn, T. W., & Jarrett, R. B. (2007). Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy’s effects. Journal of Consulting and

Clinical Psychology, 75(3), 475–488. doi:10.1037/0022-006X.75.3.475

Vittengl, J. R., & Jarrett, R. B. (2015). Cognitive therapy to prevent depressive relapse in adults. Current Opinion

in Psychology, 4, 26–31. doi:10.1016/j.copsyc.2015.01.016

Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., … Murray, C. J. L. (2017). Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet,

390(10100), 1211–1259. doi:10.1016/S0140-6736(17)32154-2

Vos, T., Corry, J., Haby, M. M., Carter, R., Andrews, G., Wales, S., & Epidemiologist, S. (2005). Cost-effectiveness of cognitive – behavioural therapy and drug interventions for major depression. Australian and New Zealand

Journal of Psychiatry, 39(8), 683–692. doi:10.1080/j.1440-1614.2005.01652.x

Wang, J. L., Patten, S., Sareen, J., Bolton, J., Schmitz, N., & Macqueen, G. (2014). Development and validation of a prediction algorithm for use by health professionals in prediction of recurrence of major depression.

Depres-sion and Anxiety, 31(5), 451–457. doi:10.1002/da.22215

Wang, P. S., Lane, M., Olfson, M., Pincus, H. A., Wells, K. B., & Kessler, R. C. (2016). Twelve-month use of mental health services in the United States. Archives of General Psychiatry, 62(6), 629–640. doi:10.1001/ archpsyc.62.6.629

Wells, P. S., Anderson, D. R., Bormanis, J., Guy, F., Mitchell, M., Gray, L., … Lewandowski, B. (1997). Value of as-sessment of pretest probability of deep-vein thrombosis in clinical management, 350, 1795–1798. doi:10.1016/ S0140-6736(97)08140-3

Wells, P. S., Hirsh, J., Anderson, D. R., Lensing, A. W., Foster, G., Kearon, C., … Prandoni, P. (1995). Accura-cy of clinical assessment of deep-vein thrombosis. The Lancet, 345(8961), 1326–1330. doi:10.1016/S0140-6736(95)92535-X

(17)

White, I. R., & Carlin, J. B. (2010). Bias and efficiency of multiple imputation compared with complete-case anal-ysis for missing covariate values. Statistics in Medicine, 29(28), 2920–2931. doi:10.1002/sim.3944

White, I. R., Royston, P., & Wood, A. M. (2011). Multiple imputation using chained equations: issues and guidance for practice. Statistics in Medicine, 30(4), 377–399. doi:10.1002/sim.4067

Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., … Vos, T. (2013). Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Dis-ease Study 2010. The Lancet, 382(9904), 1575–1586. doi:10.1016/S0140-6736(13)61611-6

Williams, J. M. G., Crane, C., Barnhofer, T., Brennan, K., Duggan, D. S., Fennell, M. J. V., … Russell, I. T. (2014). Mindfulness-based cognitive therapy for preventing relapse in recurrent depression: a randomized dismantling trial. Journal of Consulting and Clinical Psychology, 82(2), 275–286. doi:10.1037/a0035036

World Health Organization. (2017). Depression: let’s talk. Retrieved from http://www.who.int/campaigns/world-health-day/2017/en/.

Zhou, T., Li, X., Pei, Y., Gao, J., & Kong, J. (2016). Internet-based cognitive behavioural therapy for subthreshold depression: a systematic review and meta-analysis. BMC Psychiatry, 16(1), 1–25. doi:10.1186/s12888-016-1061-9

Zimmerman, M., Ellison, W., Young, D., Chelminski, I., & Dalrymple, K. (2015). How many different ways do patients meet the diagnostic criteria for major depressive disorder? Comprehensive Psychiatry, 56, 29–34. doi:10.1016/j.comppsych.2014.09.007

Zorginstituut Nederland. Richtlijn voor het uitvoeren van economische evaluaties in de gezondheidszorg. Zorgin-stituut Nederland, editor: ZorginZorgin-stituut Nederland; 2015a.

Zorginstituut Nederland. Kostenhandleiding: methodologie van kostenonderzoek en referentieprijzen voor econ-omische evaluaties in de gezondheidszorg. Geactualiseerde versie 2015. Zorginstituut Nederland, editor: Zorginstituut Nederland; 2015b.

Zorginstituut Nederland. Kosteneffectiviteit in de praktijk. Zorginstituut Nederland, editor: Zorginstituut Neder-land; 2015c.

(18)
(19)

Referenties

GERELATEERDE DOCUMENTEN

The relationship between total score and risk of recurrence (1-survival probability) was presented graphically. Finally, the total score was subdivided into the categories

The current study aimed to explore beliefs about the causes of depression and recovery (i.e., causal beliefs) in remitted recurrently depressed individuals and to examine whether they

Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive

Regarding antidepressants alone compared with PCT while tapering antidepressants, Table 2 and the CEPs (Figure 2) show that most (73% for depression-free days and 81% for QALYs)

The short-term (secondary) results of the current randomized controlled trial showed a more favorable course on depressive symptoms over 3 months in participants receiving

A recent individual-participant data meta- analysis on the cost-effectiveness of guided Internet-based interventions for depression based on five studies concluded that

We presented a simple clinical prediction tool to estimate the individual risk of depressive recurrence, we explored beliefs about the causes of depression and recovery in

Alhoewel er factoren zijn die de externe validiteit kunnen hebben verminderd, zoals de exclusiecriteria en het feit dat zich mensen kunnen hebben aangemeld met